CD40LG and amyloidosis: Seventeen patients (45%) were non-amyloidosis, including 12 patients (32%) with cryoglobulinemic glomerulonephritis (GN), 3 patients (8%) with proliferative GN with monoclonal IgM deposits, 1 patient (3%) with light-chain deposition disease (LCDD), and 1 patient (3%) with C3 GN.